AJANTPHARM

AJANTA PHARMA

Mid Cap BSE: 532331 NSE: AJANTPHARM
₹1274.5
-2.05 (-0.16%)
As on 18 August, 2022 | 03:57

Ajanta Pharma Share Price

Ajanta Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Ajanta Pharma Share Returns

  • Over 1 Month 5.62%
  • Over 3 Month 12.02%
  • Over 6 Month -5.02%
  • Over 1 Year -17.57%

Ajanta Pharma Key Statistics

P/E Ratio 23
PEG Ratio 4.6
Market Cap Cr 16,330
Price to Book Ratio 5
EPS 56.2
Dividend 0.5
Relative Strength Index 56.69
Money Flow Index 51.32
MACD Signal 14.93
Average True Range 25.9

Ajanta Pharma Investment Rating

  • Master Rating:
  • Ajanta Pharma has an operating revenue of Rs. 3,543.93 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 27% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 21% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 850
  • 766
  • 809
  • 824
  • 743
  • 748
  • Operating Expenses Qtr Cr
  • 664
  • 578
  • 571
  • 591
  • 510
  • 501
  • Operating Profit Qtr Cr
  • 186
  • 187
  • 238
  • 233
  • 233
  • 247
  • Depreciation Qtr Cr
  • 31
  • 30
  • 31
  • 30
  • 30
  • 29
  • Interest Qtr Cr
  • 1
  • 7
  • 1
  • 0
  • 1
  • 2
  • Tax Qtr Cr
  • 40
  • 43
  • 40
  • 58
  • 40
  • 62
  • Net Profit Qtr Cr
  • 150
  • 135
  • 195
  • 197
  • 193
  • 155

Ajanta Pharma Technicals

EMA & SMA

Current Price
1274.5
-2.05 (-0.16%)
  • Bullish Moving Average
  • ___
  • 10
  • Bearish Moving Average
  • ___
  • 6
  • 20 Day
  • 1268.1
  • 50 Day
  • 1243.46
  • 100 Day
  • 1245.01
  • 200 Day
  • 1294.06
  • 20 Day
  • 1280.63
  • 50 Day
  • 1236.4
  • 100 Day
  • 1202.46
  • 200 Day
  • 1293.65

Ajanta Pharma Resistance and Support

PIVOT
₹1275.22
Resistance
  • First Resistance
  • 1283.34
  • Second Resistance
  • 1290.12
  • Third Resistance
  • 1298.24
Support
  • First Resistance
  • 1268.44
  • Second Resistance
  • 1260.32
  • Third Resistance
  • 1253.54
  • RSI
  • 56.69
  • MFI
  • 51.32
  • MACD Single Line
  • 14.93
  • MACD
  • 11.75

Ajanta Pharma Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 157,627
  • 14,394,498
  • 91.32
  • Week
  • 71,743
  • 5,817,640
  • 81.09
  • 1 Month
  • 103,570
  • 7,694,238
  • 74.29
  • 6 Month
  • 97,388
  • 6,332,182
  • 65.02

Ajanta Pharma Result Highlights

Ajanta Pharma Synopsis

NSE-Medical-Generic Drugs

Ajanta Pharma Lt is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3140.64 Cr. and Equity Capital is Rs. 17.17 Cr. for the Year ended 31/03/2022. Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059.
  • Market Cap
  • 16,330
  • Sales
  • 3,248
  • Shares in Float
  • 3.84
  • No of funds
  • 180
  • Yield
  • 0.75
  • Book Value
  • 5.15
  • U/D Vol ratio
  • 1.4
  • LTDebt / Equity
  • Alpha
  • -0.08
  • Beta
  • 0.41

Ajanta Pharma

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 70.48%
  • 70.48%
  • 70.34%
  • Mutual Funds
  • 10.88%
  • 10.5%
  • 10.74%
  • Insurance Companies
  • 1.04%
  • 1.11%
  • 0.81%
  • Foreign Portfolio Investors
  • 8.3%
  • 8.64%
  • 8.95%
  • Financial Institutions/ Banks
  • Individual Investors
  • 7.46%
  • 7.33%
  • 7.29%
  • Others
  • 1.84%
  • 1.94%
  • 1.87%

Ajanta Pharma Management

  • Name
  • Designation
  • Mr. Mannalal B Agrawal
  • Chairman
  • Mr. Madhusudan B Agrawal
  • Vice Chairman
  • Mr. Yogesh M Agrawal
  • Managing Director
  • Mr. Rajesh M Agrawal
  • Joint Managing Director
  • Dr. Anjana Grewal
  • Independent Director
  • Mr. Chandrakant M Khetan
  • Independent Director
  • Mr. K H Viswanathan
  • Independent Director
  • Mr. Prabhakar R Dalal
  • Independent Director

Ajanta Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ajanta Pharma Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-28
  • Quarterly Results
  • 2022-05-10
  • Audited Results & Bonus issue
  • 2022-01-31
  • Quarterly Results
  • 2021-12-28
  • Buy Back of Shares
  • 2021-10-29
  • Quarterly Results & Interim Dividend
  • Date
  • Purpose
  • Remarks
  • 2021-11-10
  • INTERIM
  • Rs.9.50 per share(475%)Interim Dividend
  • Date
  • Purpose
  • Remarks
  • 2022-06-23
  • Bonus
  • Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma MF Shareholding

  • Name
  • Amount(cr)
  • HDFC Balanced Advantage Fund Growth
  • 46130
  • Mirae Asset Large Cap Fund Regular Growth
  • 32913
  • UTI Flexi Cap Fund Regular Plan Growth
  • 25448
  • Mirae Asset Emerging Bluechip Fund Growth
  • 22741
  • Nippon India Small Cap Fund - Growth
  • 20363

Ajanta Pharma FAQs

What is Share Price of Ajanta Pharma ?

Ajanta Pharma share price is ₹1274 As on 18 August, 2022 | 03:43

What is the Market Cap of Ajanta Pharma ?

The Market Cap of Ajanta Pharma is ₹16329.6 Cr As on 18 August, 2022 | 03:43

What is the P/E ratio of Ajanta Pharma ?

The P/E ratio of Ajanta Pharma is 23 As on 18 August, 2022 | 03:43

What is the PB ratio of Ajanta Pharma ?

The PB ratio of Ajanta Pharma is 5 As on 18 August, 2022 | 03:43

Q1FY23